Results 51 to 60 of about 5,108,464 (344)

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women. [PDF]

, 2014
Familial breast and ovarian cancer prevalence was assessed among 1150 women of Mexican descent enrolled in a case-only, binational breast cancer study. Logistic regression was conducted to compare odds of triple negative breast cancer (TNBC) to non-TNBC ...
Anderson, Kristin, Bondy, Melissa, Brewster, Abenaa, Daneri-Navarro, Adrian, Gutierrez-Millan, Luis Enrique, Komenaka, Ian K, Madlensky, Lisa, Martin, Lorena, Martínez, María Elena, Meza-Montenegro, Maria Mercedes, Natarajan, Loki, Thompson, Patricia A, Tobias, Malaika, Wertheim, Betsy C   +13 more
core   +2 more sources

The accurate staging of ovarian cancer using 3T magnetic resonance imaging - a realistic option [PDF]

, 2008
Objectives: The aim of the study was to determine whether staging primary ovarian cancer using 3.0 Tesla (3T) magnetic resonance imaging (MRI) is comparable to surgical staging of the disease.
Booth, SJ, Poole, DR, Richmond, I, Turnbull, LW   +3 more
core   +1 more source

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions

Nature Communications, 2019
OPCML is a tumour suppressor gene that is epigenetically silenced in ovarian cancer and is somatically mutated in various cancers. Here, the authors solve the X-ray crystal structure of OPCML and model clinically relevant mutations that could contribute ...
James R. Birtley, Mohammad Alomary, Elisa Zanini, Jane Antony, Zachary Maben, Grant C. Weaver, Claudia Von Arx, Manuela Mura, Aline T. Marinho, Haonan Lu, Eloise V. N. Morecroft, Evdoxia Karali, Naomi E. Chayen, Edward W. Tate, Mollie Jurewicz, Lawrence J. Stern, Chiara Recchi, Hani Gabra   +17 more
doaj   +1 more source

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

International Journal of Gynecological Cancer, 2019
The development of guidelines is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients ...
N. Colombo, N. Colombo, C. Sessa, A. Bois, J. Ledermann, W. McCluggage, I. McNeish, P. Morice, S. Pignata, I. Ray-Coquard, I. Vergote, T. Baert, I. Belaroussi, A. Dashora, S. Olbrecht, F. Planchamp, D. Querleu   +16 more
semanticscholar   +2 more sources

Epigenetics in ovarian cancer: premise, properties, and perspectives. [PDF]

, 2018
Malignant ovarian tumors bear the highest mortality rate among all gynecological cancers. Both late tumor diagnosis and tolerance to available chemical therapy increase patient mortality.
Huang, Shuang, Lau, Bonnie, Lau, Wayne Bond, Tang, Kexin, Wang, Hongjing, Wang, Wei, Wang, Xin, Wei, Yuquan, Xu, Lian, Yang, Qilian, Yang, Yuqing, Yang, Zhengnan, Yi, Tao, Zhao, Linjie, Zhao, Xia, Zhou, Nianxin, Zhou, Shengtao   +16 more
core   +2 more sources

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.

Journal of Clinical Oncology, 2020
PURPOSE To provide recommendations on genetic and tumor testing for women diagnosed with epithelial ovarian cancer based on available evidence and expert consensus.
P. Konstantinopoulos, B. Norquist, C. Lacchetti, D. Armstrong, R. Grisham, P. Goodfellow, E. Kohn, D. Levine, Joyce F. Liu, K. Lu, Dee Sparacio, C. Annunziata   +11 more
semanticscholar   +1 more source

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

Scientific Reports, 2023
Low grade serous ovarian carcinoma (LGSOC) demonstrates unique clinical and molecular features compared to other ovarian cancer types. The relationship between common histological features of LGSOC and molecular events, such as hormone receptor ...
Robert L. Hollis, John P. Thomson, Juliette van Baal, Narthana Ilenkovan, Michael Churchman, Koen van de Vijver, Frederike Dijk, Alison M. Meynert, Clare Bartos, Tzyvia Rye, Ian Croy, Patricia Diana, Mignon van Gent, Helen Creedon, Rachel Nirsimloo, Christianne Lok, Charlie Gourley, C. Simon Herrington   +17 more
doaj   +1 more source

Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. [PDF]

, 2015
The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker.
Anastasi, Emanuela, Angeloni, Antonio, Granato, T, Manganaro, Lucia, Petri, L, Porpora, Maria Grazia, Viggiani, Valentina   +6 more
core   +1 more source

The Challenges and Opportunities of lncRNAs in Ovarian Cancer Research and Clinical Use [PDF]

, 2020
[Abstract] Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor.
Barreiro-Alonso, Aida, Cerdán, María Esperanza, Lamas, Mónica, Quindós-Varela, María, Rodríguez-Belmonte, Esther, Salamini-Montemurri, Martín, Vizoso-Vázquez, Ángel   +6 more
core   +1 more source

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

Breast Cancer, 2020
Breast cancer is a common cancer affecting a large number of patients. Notably, 5–10% of all breast cancer patients are genetically predisposed to cancers.
Reiko Yoshida
semanticscholar   +1 more source